Literature DB >> 1416838

Resistance of herpesviruses to antiviral drugs.

P A Chatis1, C S Crumpacker.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1416838      PMCID： PMC191999          DOI： 10.1128/AAC.36.8.1589

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  74 in total

1.  Resistance of herpes simplex to acyclovir.

Authors:  H H Balfour
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

2.  Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.

Authors:  J C Wade; C McLaren; J D Meyers
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

3.  Intracerebral inoculation of newborn and adult mice with thymidine kinase-deficient mutants of herpes simplex virus type 1.

Authors:  R B Tenser
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

4.  Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro.

Authors:  J F Manischewitz; G V Quinnan; H C Lane; A E Wittek
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

5.  Structure-function studies of the herpes simplex virus type 1 DNA polymerase.

Authors:  M L Haffey; J Novotny; R E Bruccoleri; R D Carroll; J T Stevens; J T Matthews
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.

Authors:  P Ljungman; M N Ellis; R C Hackman; D H Shepp; J D Meyers
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

7.  Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.

Authors:  C J Birch; G Tachedjian; R R Doherty; K Hayes; I D Gust
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

8.  Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy.

Authors:  C C Linnemann; K K Biron; W G Hoppenjans; A M Solinger
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

9.  Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.

Authors:  S Safrin; T Assaykeen; S Follansbee; J Mills
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

10.  Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.

Authors:  C S Crumpacker; P N Kowalsky; S A Oliver; L E Schnipper; A K Field
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205
View more
  22 in total

1.  Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test.

Authors:  A P Cullen; C D Long; A T Lörincz
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 2.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 3.  Current recommendations for the treatment of genital herpes.

Authors:  D T Leung; S L Sacks
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

4.  Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia.

Authors:  J G Jacobson; K L Ruffner; M Kosz-Vnenchak; C B Hwang; K K Wobbe; D M Knipe; D M Coen
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.

Authors:  A M Bonneau; P Kibler; P White; C Bousquet; N Dansereau; M G Cordingley
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 6.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

Authors:  A K Field; K K Biron
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

7.  Continuous infusion of acyclovir is more effective than discontinuous infusion for treatment of genital herpes in an immunocompromised patient.

Authors:  L Mock; L Dossou-Gbété; M Merle-Melet; A Gérard
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

8.  Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates.

Authors:  J J McSharry; N S Lurain; G L Drusano; A L Landay; M Notka; M R O'Gorman; A Weinberg; H M Shapiro; P S Reichelderfer; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

9.  Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.

Authors:  S Koyano; T Suzutani; I Yoshida; M Azuma
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.

Authors:  Jianmin Duan; Michel Liuzzi; William Paris; Francine Liard; Abigail Browne; Nathalie Dansereau; Bruno Simoneau; Anne-Marie Faucher; Michael G Cordingley
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.